Disclosed herein is the use of 5-methyl-1,3-benzenediol derivatives as represented by the compounds of formula I-IV in the manufacture of a medicament of a functional food for use in treating or preventing depression or its symptoms, in particular, circadian rhythm disorders, sleep disorders, chronic stress, anxiety, acute stress-induced impairment, or cognitive functional impairment or disorders.